Brief: Vbl Therapeutics Provides Corporate Update
25/03/2021 11:09
March 25 (Reuters) - Vascular Biogenics Ltd VBLT.O :
* VBL THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2020
FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* VASCULAR BIOGENICS - AS OF DEC 31, 2020, HAD CASH, CASH
EQUIVALENTS, SHORT-TERM BANK DEPOSITS AND RESTRICTED BANK
DEPOSIT TOTALING $30.8 MILLION
* VASCULAR BIOGENICS - EXPECTS CASH, CASH EQUIVALENTS,
SHORT-TERM
BANK DEPOSITS WILL BE ENOUGH TO FUND OPERATING EXPENSES, CAPEX
REQUIREMENTS INTO Q4 2022
Source text for Eikon: ID:nGNX74xtgt
Further company coverage: VBLT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives